fbpx

Tag: two doses with a 21-day interval

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (Anvisa), on Thursday, April 8, authorized Phase 3 trials in Brazil of one more vaccine against Covid-19. The immunizer is being developed by the biopharmaceutical Medicago R&D Inc. from...

LATEST NEWS

WEATHER

Rio de Janeiro
clear sky
28.8 ° C
31 °
27 °
61 %
7.2kmh
0 %
Sat
27 °
Sun
30 °
Mon
33 °
Tue
25 °
Wed
26 °
error: Content is protected !!